History | Ceritinib for untreated ALK-positive non-small-cell lung cancer | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 221 KB)

Published:

24 January 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 312 KB)

Published:

07 December 2017
Committee papers (PDF 18.7 MB)

Published:

07 December 2017
Public committee slides Clinical slides (PDF 533 KB)

Published:

07 December 2017
Public committee slides Cost slides (PDF 327 KB)

Published:

07 December 2017

Invitation to participate

Final scope (PDF 252 KB)

Published:

30 May 2017
Draft scope and provisional matrix comments table (post-referral) (PDF 265 KB)

Published:

30 May 2017
Equality impact assessment (Scoping) (PDF 173 KB)

Published:

30 May 2017
Final matrix (PDF 337 KB)

Published:

30 May 2017